Korea Investment CORP reduced its position in Danaher Corporation (NYSE:DHR) by 31.3% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 318,828 shares of the conglomerate’s stock after selling 145,258 shares during the period. Korea Investment CORP’s holdings in Danaher Corporation were worth $26,906,000 as of its most recent filing with the SEC.
Other large investors have also recently modified their holdings of the company. Israel Discount Bank of New York acquired a new stake in Danaher Corporation in the 1st quarter valued at about $209,000. DE Burlo Group Inc. lifted its stake in Danaher Corporation by 17.8% in the 1st quarter. DE Burlo Group Inc. now owns 131,450 shares of the conglomerate’s stock valued at $11,242,000 after purchasing an additional 19,900 shares during the last quarter. Perkins Coie Trust Co lifted its stake in Danaher Corporation by 2.0% in the 2nd quarter. Perkins Coie Trust Co now owns 29,431 shares of the conglomerate’s stock valued at $2,484,000 after purchasing an additional 586 shares during the last quarter. Eastern Bank lifted its stake in Danaher Corporation by 4,291.1% in the 2nd quarter. Eastern Bank now owns 128,001 shares of the conglomerate’s stock valued at $10,802,000 after purchasing an additional 125,086 shares during the last quarter. Finally, Chevy Chase Trust Holdings Inc. lifted its stake in Danaher Corporation by 1.4% in the 2nd quarter. Chevy Chase Trust Holdings Inc. now owns 977,381 shares of the conglomerate’s stock valued at $82,481,000 after purchasing an additional 13,689 shares during the last quarter. Institutional investors and hedge funds own 75.68% of the company’s stock.
Several equities research analysts have issued reports on the stock. Credit Suisse Group restated a “buy” rating and set a $93.00 price objective on shares of Danaher Corporation in a research report on Wednesday, May 24th. Janney Montgomery Scott downgraded shares of Danaher Corporation from a “buy” rating to a “neutral” rating in a research report on Wednesday, June 7th. BidaskClub downgraded shares of Danaher Corporation from a “hold” rating to a “sell” rating in a research report on Thursday, June 15th. Zacks Investment Research downgraded shares of Danaher Corporation from a “hold” rating to a “sell” rating in a research report on Monday, June 19th. Finally, Deutsche Bank AG restated a “buy” rating and set a $97.00 price objective on shares of Danaher Corporation in a research report on Wednesday, June 21st. One analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus price target of $92.72.
In other Danaher Corporation news, Director Linda P. Hefner sold 10,578 shares of the stock in a transaction that occurred on Friday, July 21st. The shares were sold at an average price of $83.03, for a total value of $878,291.34. Following the sale, the director now directly owns 42,151 shares in the company, valued at approximately $3,499,797.53. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider William King sold 43,688 shares of the stock in a transaction that occurred on Thursday, August 31st. The stock was sold at an average price of $82.86, for a total transaction of $3,619,987.68. Following the completion of the sale, the insider now owns 45,748 shares in the company, valued at $3,790,679.28. The disclosure for this sale can be found here. Insiders have sold a total of 71,496 shares of company stock worth $5,916,223 over the last 90 days. 12.20% of the stock is currently owned by corporate insiders.
COPYRIGHT VIOLATION WARNING: This article was posted by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this article on another website, it was illegally stolen and republished in violation of United States and international copyright & trademark law. The correct version of this article can be read at https://stocknewstimes.com/2017/09/20/korea-investment-corp-reduces-stake-in-danaher-corporation-dhr.html.
Danaher Corporation (NYSE DHR) opened at 86.87 on Wednesday. The company has a market capitalization of $60.35 billion, a PE ratio of 27.73 and a beta of 1.03. Danaher Corporation has a 52 week low of $75.71 and a 52 week high of $88.62. The company has a 50-day moving average of $82.99 and a 200-day moving average of $84.20.
Danaher Corporation (NYSE:DHR) last announced its quarterly earnings results on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, beating the Zacks’ consensus estimate of $0.97 by $0.02. The company had revenue of $4.51 billion for the quarter, compared to analysts’ expectations of $4.50 billion. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. Danaher Corporation’s revenue was up 6.3% compared to the same quarter last year. During the same period in the prior year, the company posted $0.90 EPS. On average, equities research analysts anticipate that Danaher Corporation will post $3.95 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, September 29th will be paid a dividend of $0.14 per share. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.64%. The ex-dividend date is Thursday, September 28th. Danaher Corporation’s payout ratio is currently 17.83%.
About Danaher Corporation
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.